These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 6469435)
1. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus. Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435 [TBL] [Abstract][Full Text] [Related]
2. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)]. Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656 [TBL] [Abstract][Full Text] [Related]
3. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Supapannachart S; Limrungsikul A; Khowsathit P J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of indomethacin in the premature infant. Bianchetti G; Monin P; Marchal F; Dubruc C; Boutroy MJ; Morselli PL; Vert P Dev Pharmacol Ther; 1980; 1(2-3):111-24. PubMed ID: 6927544 [TBL] [Abstract][Full Text] [Related]
5. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome. Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480 [TBL] [Abstract][Full Text] [Related]
6. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Chotigeat U; Jirapapa K; Layangkool T J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. Brash AR; Hickey DE; Graham TP; Stahlman MT; Oates JA; Cotton RB N Engl J Med; 1981 Jul; 305(2):67-72. PubMed ID: 7242577 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic closure of patent ductus arteriosus in the premature infant. Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994 [TBL] [Abstract][Full Text] [Related]
9. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Cherif A; Jabnoun S; Khrouf N Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958 [TBL] [Abstract][Full Text] [Related]
10. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants]. Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030 [TBL] [Abstract][Full Text] [Related]
11. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels. Yeh TF; Achanti B; Patel H; Pildes RS Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus]. Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560 [TBL] [Abstract][Full Text] [Related]
14. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants]. Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265 [TBL] [Abstract][Full Text] [Related]
15. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317 [TBL] [Abstract][Full Text] [Related]
17. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. Itabashi K; Ohno T; Nishida H J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633 [TBL] [Abstract][Full Text] [Related]
18. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. Heymann MA; Rudolph AM; Silverman NH N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959 [TBL] [Abstract][Full Text] [Related]
19. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus. Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745 [TBL] [Abstract][Full Text] [Related]
20. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. Leonhardt A; Strehl R; Barth H; Seyberth HW Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]